InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| QUANTI-Luc™: Luciferase Detection Reagent | SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly i... | 2022 | Sci Rep | Song C. et al. | DOI: 10.1038/s41598-022-12449-1 |
| MRT67307 | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |
| BX795 | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |
| RU.521 | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |
| STING inhibitor | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |
| Pam3CSK4 | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |
| ODN TTAGGG (A151) | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |
| Bafilomycin A1 | HIV-1-induced type I Interferons promote viral latency in macrophages. | 2022 | J Leukoc Biol. | Dickey L.L. et al. | DOI: 10.1002/JLB.4MA0422-616R |
| ODN 2216 - TLR9 ligand | Low Density Lipoprotein Exposure of Plasmacytoid Dendritic Cells Blunts Toll-... | 2022 | Biomedicines | Christ A. et al. | DOI: 10.3390/biomedicines10051152 |
| Imiquimod VacciGrade™ (R837) | Low Density Lipoprotein Exposure of Plasmacytoid Dendritic Cells Blunts Toll-... | 2022 | Biomedicines | Christ A. et al. | DOI: 10.3390/biomedicines10051152 |
| LPS-RS | Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TL... | 2022 | Nat Commun. | Meng J.X. et al. | DOI: 10.1038/s41467-022-30461-x |
| AddaVax™ | Targeted mutagenesis in Anaplasma marginale to define virulence and vaccine d... | 2022 | PLoS Pathog | Hove P. et al. | DOI: 10.1371/journal.ppat.1010540 |
| G418 (Geneticin) | CD4 + T-cell epitope-based heterologous prime-boost vaccination potentiates a... | 2022 | J Immunother Cancer | Xiao M. et al. | DOI: 10.1136/jitc-2021-004022 |
| G418 (Geneticin) | Structure-based peptide ligand design for improved epidermal growth factor re... | 2022 | Eur J Pharm Biopharm | Decker S. et al. | DOI: 10.1016/j.ejpb.2022.05.004 |
| Zeocin® | Structure-based peptide ligand design for improved epidermal growth factor re... | 2022 | Eur J Pharm Biopharm | Decker S. et al. | DOI: 10.1016/j.ejpb.2022.05.004 |
| ODN INH-18 | Mitochondrial transcription factor B2 overexpression increases M2 macrophage ... | 2022 | Bioengineered | Wu W. et al. | DOI: 10.1080/21655979.2022.2074615 |
| pFUSE-CHIg-hG1 | Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induc... | 2022 | Cell Rep Med. | Heydarchi B. et al. | DOI: 10.1016/j.xcrm.2022.100635 |
| pFUSE2-CLIg-hL2 | Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induc... | 2022 | Cell Rep Med. | Heydarchi B. et al. | DOI: 10.1016/j.xcrm.2022.100635 |
| Anti-mouse Dectin-1 (CLEC7A) antibody | Candida albicans oscillating UME6 expression during intestinal colonization p... | 2022 | Cell Rep. | Shao T.Y. et al. | DOI: 10.1016/j.celrep.2022.110837 |
| QUANTI-Blue™ | Candida albicans oscillating UME6 expression during intestinal colonization p... | 2022 | Cell Rep. | Shao T.Y. et al. | DOI: 10.1016/j.celrep.2022.110837 |